| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/08/2008 | US7396933 Quinolinone-carboxamide compounds |
| 07/08/2008 | US7396839 Heating in solvent; controlling temperature; cooling; isolation; drying |
| 07/08/2008 | US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | CA2505506C Compounds which can be used to diagnose and monitor diseases associated with the formation of amyloid protein fibrils |
| 07/03/2008 | WO2008079683A2 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain |
| 07/03/2008 | WO2008079316A1 Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof |
| 07/03/2008 | WO2008078824A1 Benzofluoranthene compound and organic light-emitting device using the compound |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008077305A1 Quinoline compounds, intermediates, prepartion methods and uses thereof |
| 07/03/2008 | WO2008049922A3 A new process for the preparation of montelukast |
| 07/03/2008 | WO2008041088A3 N-hydroxy benzamides with antitumor activity |
| 07/03/2008 | US20080161575 Using 3-(4-acetamido-3-chloroanilino)- 2-cyanopropionenic acid ester ester as chemical intermediate; acylation, alkylation, reduction, cyclization, chlorination, hydrolysis |
| 07/03/2008 | US20080161353 8-Hydroxy quinoline derivatives |
| 07/03/2008 | US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161350 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 07/03/2008 | US20080161349 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/03/2008 | US20080161344 Melanin Concentrating Hormone Receptor Ligands: Substituted Tetrahydroisoquinoline Analogues |
| 07/03/2008 | US20080161340 Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | CA2672196A1 Antagonists of the trpv1 receptor and uses thereof |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2651942A1 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| 07/02/2008 | EP1937642A2 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 07/02/2008 | EP1937641A2 Dihydro-[1h]-quinolin-2-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/02/2008 | EP1937640A2 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/02/2008 | EP1729773B1 8-hydroxy-5- [(-hydroxy-2- [[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation |
| 07/02/2008 | EP1648858B1 Method for production of alpha, beta-unsaturated amide compounds |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | CN101213177A Purification of montelukast |
| 07/02/2008 | CN101212973A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 07/02/2008 | CN101212972A 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 07/02/2008 | CN101212971A 4-phenyl-5-0x0-l,4,5,6,7,8-hexahydr0quin0line derivatives as medicaments for the treatment of infertility |
| 07/02/2008 | CN101209974A Hydroxamic acids derivatives and use thereof |
| 07/02/2008 | CN100398094C Formoterol superfine formulation |
| 07/01/2008 | US7393958 Triamide-substituted heterobicyclic compounds |
| 07/01/2008 | US7393957 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 06/26/2008 | WO2008076427A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 06/26/2008 | WO2008075025A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | WO2008074692A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |
| 06/26/2008 | WO2008035086A3 Synthesis of leukotriene compounds |
| 06/26/2008 | US20080153871 Antagonists of the trpv1 receptor and uses thereof |
| 06/26/2008 | US20080153859 5-{[6-Fluoro-2,5-dihydroxy-4,4,7-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-isoquinolin-1(2H)-one; anti-allergic, immunosuppressive and antiproliferative action |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153799 Novel Quinoline-Carbaxamides as Jak3 Kinase Modulators |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/26/2008 | CA2672792A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 06/26/2008 | CA2672761A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cpti) |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1934205A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 06/25/2008 | EP1934186A2 Renin inhibitors nitroderivatives |
| 06/25/2008 | EP1934183A1 Methods of preparing anhydrous aripiprazole form ii |
| 06/25/2008 | CN101208304A Quinoline 3-sulfonate esters as NK3 receptor modulators |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine |
| 06/24/2008 | US7390806 Antibiotics containing borinic acid complexes and methods of use |
| 06/19/2008 | WO2008072872A1 Method of preparing montelukast and intermediates used therein |
| 06/19/2008 | WO2008072850A1 Triazine derivatives having inhibitory activity against acetyl-coa carboxylase |
| 06/19/2008 | WO2008044027A3 Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| 06/19/2008 | US20080146809 Process for the Preparation of Novel Amorphous Montelukast Sodium |
| 06/19/2008 | US20080146803 Antibiotics containing borinic acid complexes and methods of use |
| 06/19/2008 | US20080146647 Acetylene derivatives having mglur 5 antagonistic activity |
| 06/19/2008 | US20080146611 Transient Receptor Potential channel modulators; N-(2-pyridinyloxy- or 2-pyridinylthio-alkanoyl)quinolines; acute or chronic pain, sensitivity, burns, diabetic neuropathy, psoriasis, eczema, dermatitis, post-herpetic neuralgia, migraine, incontinence, fever, hot flashes, osteoarthritis; depilatories |
| 06/19/2008 | US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents |
| 06/19/2008 | US20080146604 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders |
| 06/19/2008 | US20080146567 5-HT5A receptor antagonists; depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, drug withdrawal |
| 06/19/2008 | US20080146564 the major cause of lower respiratory tract illness during infancy and childhood |
| 06/19/2008 | US20080146554 Substituted Cycloalkyl Derivatives, Process for the Manufacture thereof and Use thereof as Medicament |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/19/2008 | DE102007012794B3 New pyrido(3,2-h)quinazoline compounds useful to prepare doped organic semi-conductor, which is useful in an organic light-emitting diode, preferably organic solar cells, and modules for an electronic circuits, preferably displays |
| 06/18/2008 | EP1931657A2 Novel high affinity quinoline-based kinase ligands |
| 06/18/2008 | EP1931635A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 06/18/2008 | CN101203522A Antineoplastic compounds and pharmaceutical compositions thereof |
| 06/18/2008 | CN101203494A Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof |
| 06/18/2008 | CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 06/18/2008 | CN100395244C Quinolone carboxylic acid derivatives or their salts |
| 06/18/2008 | CN100395231C Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile |
| 06/17/2008 | US7388018 for controlling phytopathogenic harmful fungi; |
| 06/17/2008 | US7388012 (Hydrazido)(amino)thiophene compounds |
| 06/17/2008 | US7388008 (1-{5-[(4-amino-benzenesulfonyl)-isobutyl-amino]-6-phosphonooxy-hexacarbomoyl}-2,2-diphenyl-ethyl)-carbamic acid methyl ester; which upon cleavage of cleavable bond or unit generates HIV-1 aspartyl protease inhibitor; antiviral agent; good solubility, and bioavailability; HIV or HTLV infection |
| 06/17/2008 | CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/17/2008 | CA2272291C Crf antagonistic quino- and quinazolines |
| 06/17/2008 | CA2264118C Tetrahydroquinoline derivatives as eaa antagonists |
| 06/17/2008 | CA2163361C Therapeutic substituted guanidines |
| 06/12/2008 | WO2008069242A1 Novel bicyclic heterocyclic compound |
| 06/12/2008 | WO2008068272A2 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068270A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068269A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068268A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068267A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068266A1 Antibacterial quinoline derivatives |
| 06/12/2008 | WO2008068231A1 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 06/12/2008 | WO2008068157A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 06/12/2008 | WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 06/12/2008 | WO2007123910A3 Copper-mediated functionalization of aryl c-h bonds, and compounds related thereto |
| 06/12/2008 | WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases |